Class 001
Chemical Products
Biological preparations for pharmaceutical purposes for the treatment of pain, itch, diabetes, cancer, and inflammation and inflammatory diseases, namely inflammatory skin conditions namely atopic dermatitis, flea allergy dermatitis, pruritis, and pemphigus, inflammatory conditions of the internal organs namely inflammatory bowel disease, chronic kidney disease, pancreatitis, cystitis, immune-mediated hemolytic anemia, systemic lupus, erythematosus, hyper-eosinophilic syndromes, and diabetes, inflammations of the ear namely otitis externa, otitis interna, and otitis media, and inflammatory conditions of the joints namely osteoarthritis, rheumatoid arthritis, and poly arthritis; pharmaceutical preparations for the treatment of pain, itch, diabetes, cancer, and inflammation and inflammatory diseases, namely inflammatory skin conditions namely atopic dermatitis, flea allergy dermatitis, pruritis, and pemphigus, inflammatory conditions of the internal organs namely inflammatory bowel disease, chronic kidney disease, pancreatitis, cystitis, immune-mediated hemolytic anemia, systemic lupus, erythematosus, hyper-eosinophilic syndromes, and diabetes, inflammations of the ear namely otitis externa, otitis interna, and otitis media, and inflammatory conditions of the joints namely osteoarthritis, rheumatoid arthritis, and poly arthritis; pharmaceutical preparations for animals for the treatment of pain, itch, diabetes, cancer, and inflammation and inflammatory diseases, namely inflammatory skin conditions namely atopic dermatitis, flea allergy dermatitis, pruritis, and pemphigus, inflammatory conditions of the internal organs namely inflammatory bowel disease, chronic kidney disease, pancreatitis, cystitis, immune-mediated hemolytic anemia, systemic lupus, erythematosus, hyper-eosinophilic syndromes, and diabetes, inflammations of the ear namely otitis externa, otitis interna, and otitis media, and inflammatory conditions of the joints namely osteoarthritis, rheumatoid arthritis, and poly arthritis; pharmaceutical preparations for the therapeutic treatment of diabetes mellitus; pharmaceutical preparations for veterinary use for the treatment of pain, itch, diabetes, cancer, and inflammation and inflammatory diseases, namely inflammatory skin conditions namely atopic dermatitis, flea allergy dermatitis, pruritis, and pemphigus, inflammatory conditions of the internal organs namely inflammatory bowel disease, chronic kidney disease, pancreatitis, cystitis, immune-mediated hemolytic anemia, systemic lupus, erythematosus, hyper-eosinophilic syndromes, and diabetes, inflammations of the ear namely otitis externa, otitis interna, and otitis media, and inflammatory conditions of the joints namely osteoarthritis, rheumatoid arthritis, and poly arthritis; radioactive preparations for veterinary use for the treatment of pain, itch, diabetes, cancer, and inflammation and inflammatory diseases, namely inflammatory skin conditions namely atopic dermatitis, flea allergy dermatitis, pruritis, and pemphigus, inflammatory conditions of the internal organs namely inflammatory bowel disease, chronic kidney disease, pancreatitis, cystitis, immune-mediated hemolytic anemia, systemic lupus, erythematosus, hyper-eosinophilic syndromes, and diabetes, inflammations of the ear namely otitis externa, otitis interna, and otitis media, and inflammatory conditions of the joints namely osteoarthritis, rheumatoid arthritis, and poly arthritis; reagents for in-vitro laboratory use (for medical diagnostic veterinary purposes); reagents for laboratory purposes (for medical diagnostic veterinary purposes); reagents for use in analytical tests (for medical diagnostic veterinary purposes); reagents for use in diagnostic tests (for medical diagnostic veterinary purposes); reagents for use in the development of monoclonal antibodies (for veterinary purposes); reagents in kit form for conducting enzyme-linked immunosorbent assays (ELISA) (for veterinary purposes); veterinary preparations for the treatment of pain, itch, diabetes, cancer, and inflammation and inflammatory diseases, namely inflammatory skin conditions namely atopic dermatitis, flea allergy dermatitis, pruritis, and pemphigus, inflammatory conditions of the internal organs namely inflammatory bowel disease, chronic kidney disease, pancreatitis, cystitis, immune-mediated hemolytic anemia, systemic lupus, erythematosus, hyper-eosinophilic syndromes, and diabetes, inflammations of the ear namely otitis externa, otitis interna, and otitis media, and inflammatory conditions of the joints namely osteoarthritis, rheumatoid arthritis, and poly arthritis; veterinary preparations for administration by injection for the treatment of pain, itch, diabetes, cancer, and inflammation and inflammatory diseases, namely inflammatory skin conditions namely atopic dermatitis, flea allergy dermatitis, pruritis, and pemphigus, inflammatory conditions of the internal organs namely inflammatory bowel disease, chronic kidney disease, pancreatitis, cystitis, immune-mediated hemolytic anemia, systemic lupus, erythematosus, hyper-eosinophilic syndromes, and diabetes, inflammations of the ear namely otitis externa, otitis interna, and otitis media, and inflammatory conditions of the joints namely osteoarthritis, rheumatoid arthritis, and poly arthritis; veterinary preparations for the immunisation against disease for the treatment of pain, itch, diabetes, cancer, and inflammation and inflammatory diseases, namely inflammatory skin conditions namely atopic dermatitis, flea allergy dermatitis, pruritis, and pemphigus, inflammatory conditions of the internal organs namely inflammatory bowel disease, chronic kidney disease, pancreatitis, cystitis, immune-mediated hemolytic anemia, systemic lupus, erythematosus, hyper-eosinophilic syndromes, and diabetes, inflammations of the ear namely otitis externa, otitis interna, and otitis media, and inflammatory conditions of the joints namely osteoarthritis, rheumatoid arthritis, and poly arthritis; veterinary preparations for use in improving the skin for the treatment of pain, itch, diabetes, cancer, and inflammation and inflammatory diseases, namely inflammatory skin conditions namely atopic dermatitis, flea allergy dermatitis, pruritis, and pemphigus, inflammatory conditions of the internal organs namely inflammatory bowel disease, chronic kidney disease, pancreatitis, cystitis, immune-mediated hemolytic anemia, systemic lupus, erythematosus, hyper-eosinophilic syndromes, and diabetes, inflammations of the ear namely otitis externa, otitis interna, and otitis media, and inflammatory conditions of the joints namely osteoarthritis, rheumatoid arthritis, and poly arthritis; veterinary preparations for use in treating the coat for the treatment of pain, itch, diabetes, cancer, and inflammation and inflammatory diseases, namely inflammatory skin conditions namely atopic dermatitis, flea allergy dermatitis, pruritis, and pemphigus, inflammatory conditions of the internal organs namely inflammatory bowel disease, chronic kidney disease, pancreatitis, cystitis, immune-mediated hemolytic anemia, systemic lupus, erythematosus, hyper-eosinophilic syndromes, and diabetes, inflammations of the ear namely otitis externa, otitis interna, and otitis media, and inflammatory conditions of the joints namely osteoarthritis, rheumatoid arthritis, and poly arthritis; veterinary preparations in dosage forms for veterinary use for the treatment of pain, itch, diabetes, cancer, and inflammation and inflammatory diseases, namely inflammatory skin conditions namely atopic dermatitis, flea allergy dermatitis, pruritis, and pemphigus, inflammatory conditions of the internal organs namely inflammatory bowel disease, chronic kidney disease, pancreatitis, cystitis, immune-mediated hemolytic anemia, systemic lupus, erythematosus, hyper-eosinophilic syndromes, and diabetes, inflammations of the ear namely otitis externa, otitis interna, and otitis media, and inflammatory conditions of the joints namely osteoarthritis, rheumatoid arthritis, and poly arthritis; veterinary products, namely 100% species-specific monoclonal antibodies, canine or feline fusion proteins, and canine or feline insulin analogues; veterinary products for equines, namely fully equinized monoclonal antibodies, equine fusion proteins; veterinary vaccines; biological preparations for veterinary purposes for the treatment of pain, itch, diabetes, cancer, and inflammation and inflammatory diseases, namely inflammatory skin conditions namely atopic dermatitis, flea allergy dermatitis, pruritis, and pemphigus, inflammatory conditions of the internal organs namely inflammatory bowel disease, chronic kidney disease, pancreatitis, cystitis, immune-mediated hemolytic anemia, systemic lupus, erythematosus, hyper-eosinophilic syndromes, and diabetes, inflammations of the ear namely otitis externa, otitis interna, and otitis media, and inflammatory conditions of the joints namely osteoarthritis, rheumatoid arthritis, and poly arthritis; proteins for medical use in binding antibodies; proteins for medical use in detecting antibodies; proteins for medical use in recombinant DNA technology; antibodies; immunological antibodies for medical use; monoclonal antibodies for diagnostic use (medical); monoclonal antibodies for medical use; monoclonal antibodies for therapeutic purposes; products containing antibodies for use in medicine for pain, diabetes, cancer, and inflammation and inflammatory diseases, namely inflammatory skin conditions namely atopic dermatitis, flea allergy dermatitis, pruritis, and pemphigus, inflammatory conditions of the internal organs namely inflammatory bowel disease, chronic kidney disease, pancreatitis, cystitis, immune-mediated hemolytic anemia, systemic lupus, erythematosus, hyper-eosinophilic syndromes, and diabetes, inflammations of the ear namely otitis externa, otitis interna, and otitis media, and inflammatory conditions of the joints namely osteoarthritis, rheumatoid arthritis, and poly arthritis; reagents for use in the development of monoclonal antibodies (for medical purposes); tagged antibodies for medical use; biological preparations for medical purposes for the treatment of pain, itch, diabetes, cancer, and inflammation and inflammatory diseases, namely inflammatory skin conditions namely atopic dermatitis, flea allergy dermatitis, pruritis, and pemphigus, inflammatory conditions of the internal organs namely inflammatory bowel disease, chronic kidney disease, pancreatitis, cystitis, immune-mediated hemolytic anemia, systemic lupus, erythematosus, hyper-eosinophilic syndromes, and diabetes, inflammations of the ear namely otitis externa, otitis interna, and otitis media, and inflammatory conditions of the joints namely osteoarthritis, rheumatoid arthritis, and poly arthritis; biological products for medical use, namely 100% species-specific monoclonal antibodies, canine or feline fusion proteins, and canine or feline insulin analogues; biological reagents for medical diagnostic purposes for use in molecular biology; biological substances for medical use, namely 100% species-specific monoclonal antibodies, canine or feline fusion proteins, and canine or feline insulin analogues for the treatment of pain, itch, diabetes, cancer, and inflammation and inflammatory diseases, namely inflammatory skin conditions namely atopic dermatitis, flea allergy dermatitis, pruritis, and pemphigus, inflammatory conditions of the internal organs namely inflammatory bowel disease, chronic kidney disease, pancreatitis, cystitis, immune-mediated hemolytic anemia, systemic lupus, erythematosus, hyper-eosinophilic syndromes, and diabetes, inflammations of the ear namely otitis externa, otitis interna, and otitis media, and inflammatory conditions of the joints namely osteoarthritis, rheumatoid arthritis, and poly arthritis; reagents for use in biological processing (for medical diagnostic purposes); reagents for use in biological processing (for medical diagnostic veterinary purposes; therapeutic biological products (medical), namely 100% species-specific monoclonal antibodies, canine or feline fusion proteins, and canine or feline insulin analogues for the treatment of pain; monoclonal antibody reagents for medical use; therapeutic agents (medical) for the treatment of pain, itch, diabetes, cancer, and inflammation and inflammatory diseases, namely inflammatory skin conditions namely atopic dermatitis, flea allergy dermatitis, pruritis, and pemphigus, inflammatory conditions of the internal organs namely inflammatory bowel disease, chronic kidney disease, pancreatitis, cystitis, immune-mediated hemolytic anemia, systemic lupus, erythematosus, hyper-eosinophilic syndromes, and diabetes, inflammations of the ear namely otitis externa, otitis interna, and otitis media, and inflammatory conditions of the joints namely osteoarthritis, rheumatoid arthritis, and poly arthritis; therapeutic drugs (medical) for the treatment of pain, itch, diabetes, cancer, and inflammation and inflammatory diseases, namely inflammatory skin conditions namely atopic dermatitis, flea allergy dermatitis, pruritis, and pemphigus, inflammatory conditions of the internal organs namely inflammatory bowel disease, chronic kidney disease, pancreatitis, cystitis, immune-mediated hemolytic anemia, systemic lupus, erythematosus, hyper-eosinophilic syndromes, and diabetes, inflammations of the ear namely otitis externa, otitis interna, and otitis media, and inflammatory conditions of the joints namely osteoarthritis, rheumatoid arthritis, and poly arthritis; animal care products for veterinary use, namely 100% species-specific monoclonal antibodies, canine or feline fusion proteins, and canine or feline insulin analogues or recombinant proteins for the treatment of pain, itch, diabetes, cancer, and inflammation and inflammatory diseases, namely inflammatory skin conditions namely atopic dermatitis, flea allergy dermatitis, pruritis, and pemphigus, inflammatory conditions of the internal organs namely inflammatory bowel disease, chronic kidney disease, pancreatitis, cystitis, immune-mediated hemolytic anemia, systemic lupus, erythematosus, hyper-eosinophilic syndromes, and diabetes, inflammations of the ear namely otitis externa, otitis interna, and otitis media, and inflammatory conditions of the joints namely osteoarthritis, rheumatoid arthritis, and poly arthritis; biotechnological preparations for veterinary use, namely 100% species-specific monoclonal antibodies, canine or feline fusion proteins, and canine or feline insulin analogues for the treatment of pain, itch, diabetes, cancer, and inflammation and inflammatory diseases, namely inflammatory skin conditions namely atopic dermatitis, flea allergy dermatitis, pruritis, and pemphigus, inflammatory conditions of the internal organs namely inflammatory bowel disease, chronic kidney disease, pancreatitis, cystitis, immune-mediated hemolytic anemia, systemic lupus, erythematosus, hyper-eosinophilic syndromes, and diabetes, inflammations of the ear namely otitis externa, otitis interna, and otitis media, and inflammatory conditions of the joints namely osteoarthritis, rheumatoid arthritis, and poly arthritis
